Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis

PLoS Neglected Tropical Diseases

Volumn 4, Issue 6, 2010, Pages

  Lardon, Zélie ^a,b   Watier, Laurence ^a,c   Brunet, Audrey ^a   Bernéde, Claire ^a   Goudal, Maryvonne ^a   Dacheux, Laurent ^a   Rotivel, Yolande ^a   Guillemot, Didier ^a,c   Bourhy, Hervé ^a  

^a INSTITUT PASTEUR   (France)

^b VETAGRO SUP   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ARTICLE; CONSULTATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE NEED; HEALTH CARE PLANNING; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MEDICAL PRACTICE; NONHUMAN; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN ATTITUDE; PRESCRIPTION; PUBLIC HEALTH SERVICE; RABIES; SEASONAL VARIATION; TREATMENT INDICATION; ANIMAL; DOG; FRANCE; METHODOLOGY; PASSIVE IMMUNIZATION; PROPHYLAXIS; REGRESSION ANALYSIS; STATISTICS;

ANIMALS; DISEASE NOTIFICATION; DOGS; FRANCE; HUMANS; IMMUNIZATION, PASSIVE; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; REGRESSION ANALYSIS;

EID: 77957002456     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000723     Document Type: Article

References (40)

1. Covello VT (2003) Best practices in public health risk and crisis communication. J Health Commun 8(Suppl 1): discussion 148-151.
2. Freimuth V, Linnan HW, Potter P (2000) Communicating the threat of emerging infections to the public. Emerg Infect Dis 6: 337-347.
3. Kasperson RE (1986) Six propositions on public participation and their relevance for risk communication. Risk Anal 6: 275-281.
4. Blendon RJ, Benson JM, DesRoches CM, Raleigh E, Taylor-Clark K (2004) The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis 38: 925-931.
5. Nicol AM, Hurrell C, McDowall W, Bartlett K, Elmieh N (2008) Communicating the risks of a new, emerging pathogen: the case of Cryptococcus gattii. Risk Anal 28: 373-386.
6. Warrell MJ, Warrell DA (2004) Rabies and other lyssavirus diseases. Lancet 363: 959-969.
7. Coleman PG, Fevre EM, Cleaveland S (2004) Estimating the public health impact of rabies. Emerg Infect Dis 10: 140-142.
8. Bourhy H, Dacheux L, Strady C, Mailles A (2005) Rabies in Europe in 2005. EuroSurveill 10: 213-216.
9. WHO (2005) Expert consultation on rabies. World Health Organ Tech Rep Ser 931: 1-88.
10. Rotivel Y, Goudal M, De Fanti AS, Van Der Vliet D (2008) Epidemiology and prophylaxis of rabies in humans in France: evaluation and perspectives of a twenty-five year surveillance programme. Dev Biol (Basel) 131: 403-410.
11. Dacheux L, Reynes JM, Buchy P, Sivuth O, Diop BM, et al. (2008) A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 47: 1410-1417.
12. WHO position paper (2007) Rabies vaccines. Weekly Epidemiol Rec 82: 4425-4435.
13. Khawplod P, Wilde H, Chomchey P, Benjavongkulchai M, Yenmuang W, et al. (1996) What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine 14: 389-391.
14. Box GEP, Jenkins G (1976) Time series analysis: forecasting and control; ed. n, editor. Oakland, CA: Holden-Day.
15. Watier L (1995) Revue méthodologique de quelques techniques spécifiques à l'analyse des séries temporelles en épidémiologie et santé publique. Rev Epidémiol Santé Publique 43: 162-172.
16. Watier L, Richardson E (1991) A time series construction of an alert threshold with application to S. bobimorbificans in France. Stat Med 10: 1493-1509.
17. Judge GG, Griffiths WE, Carter Hill R, Lutkepohl H, Lee T-C (1985) The theory and pratice of econometrics. Wiley Series in Probability and Mathematical Statistics. 1985. New York: John Wiley & Sons.
18. Aubert M (1990) Que penser de la rage en 1990? Bulletin Epidémiologique de la Rage Animale en France 20: 1-2.
19. Toma B (2005) Fox rabies in France. Euro Surveill 10: 220-222.
20. Floret D, Bourhy H, Peigue-Lafeuille H (2005) La rage: une maladie encore présente en France! Méd Mal Infect 35: 112-113.
21. Servas V, Mailles A, Neau D, Castor C, Manetti A, et al. (2005) An imported case of canine rabies in Aquitaine: investigation and management of the contacts at risk, August 2004-March 2005. Euro Surveill 10: 222-225.
22. Gautret P, Shaw M, Gazin P, Soula G, Delmont J, et al. (2008) Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. J Travel Med 15: 25-30.
23. Gautret P, Soula G, Adamou H, Soavi MJ, Delmont J, et al. (2008) Rabies postexposure prophylaxis, Marseille, France, 1994-2005. Emerg Infect Dis 14: 1452-1454.
24. Recuenco S, Cherry B, Eidson M (2007) Potential cost savings with terrestrial rabies control. BMC Public Health 7: 47.
25. Bogel K, Meslin FX (1990) Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ 68: 281-291.
26. Dhankhar P, Vaidya SA, Fishbien DB, Meltzer MI (2008) Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine 26: 4251-4255.
27. Fishbein DB, Miranda NJ, Merrill P, Camba RA, Meltzer M, et al. (1991) Rabies control in the Republic of the Philippines: benefits and costs of elimination. Vaccine 9: 581-587.
28. Hampson K, Dobson A, Kaare M, Dushoff J, Magoto M, et al. (2008) Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis 2: e339.
29. Adelman RC, Verbrugge LM (2000) Death makes news: the social impact of disease on newspaper coverage. J Health Soc Behav 41: 347-367.
30. Bourhy H, Goudal M, Mailles A, Sadkowska-Todys M, Dacheux L, et al. (2009) Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe? Eurosurveillance 14: pii:19166.
31. Moran GJ, Talan DA, Mower W, Newdow M, Ong S, et al. (2000) Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group. Jama 284: 1001-1007.
32. Eggener S (1998) The power of the pen: medical journalism and public awareness. Jama 279: 1400.
33. Schwitzer G, Mudur G, Henry D, Wilson A, Goozner M, et al. (2005) What are the roles and responsibilities of the media in disseminating health information? PLoS Med 2: e215.
34. Bergeron SL, Sanchez AL (2005) Media effects on students during SARS outbreak. Emerg Infect Dis 11: 732-734.
35. Chang HJ, Huang N, Lee CH, Hsu YJ, Hsieh CJ, et al. (2004) The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS. Am J Public Health 94: 562-564.
36. Rezza G, Marino R, Farchi F, Taranto M (2004) SARS epidemic in the press. Emerg Infect Dis 10: 381-382.
37. Smith RD (2006) Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Soc Sci Med 63: 3113-3123.
38. Washer P (2004) Representations of SARS in the British newspapers. Soc Sci Med 59: 2561-2571.
39. Demidov VV (2002) Anthrax-related panic is more dangerous than the disease. Trends Biotechnol 20: 97.
40. Gursky E, Inglesby TV, O'Toole T (2003) Anthrax 2001: observations on the medical and public health response. Biosecur Bioterror 1: 97-110.